Melissa S. Kampmann’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.31M Sell
7,762
-99
-1% -$101K 7.03% 1
2026
Q1
$7.23M Sell
7,861
-62
-0.8% -$62.9K 5.8% 2
2025
Q4
$8.55M Sell
7,923
-61
-0.8% -$58.3K 6.32% 1
2025
Q3
$6.09M Sell
7,984
-274
-3% -$204K 4.44% 6
2025
Q2
$6.44M Sell
8,258
-253
-3% -$197K 4.83% 2
2025
Q1
$7.03M Buy
8,511
+40
+0.5% +$33.3K 5.56% 1
2024
Q4
$6.54M Sell
8,471
-1,275
-13% -$1.06M 5.14% 2
2024
Q3
$8.63M Sell
9,746
-240
-2% -$216K 6.11% 1
2024
Q2
$9.04M Sell
9,986
-889
-8% -$711K 6.6% 1
2024
Q1
$8.46M Sell
10,875
-287
-3% -$204K 6.08% 1
2023
Q4
$6.51M Sell
11,162
-1,231
-10% -$719K 5.57% 1
2023
Q3
$6.66M Buy
+12,393
New +$6.39M 6.42% 1

Other funds holding LLY

Melissa S. Kampmann's LLY Position: Q2 2026 in Review

Melissa S. Kampmann reduced its Eli Lilly (LLY) stake by 1.3% in Q2 2026, selling an estimated $101K and leaving 7,762 shares worth $9.31M. The position accounts for 7.03% of the portfolio, ranked #1.

Melissa S. Kampmann first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 2,854 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Melissa S. Kampmann held 7,762 shares of Eli Lilly worth $9.31M as of Q2 2026.
  • Melissa S. Kampmann sold 99 Eli Lilly shares in Q2 2026, an estimated $101K.
  • Eli Lilly made up 7.03% of Melissa S. Kampmann's portfolio in Q2 2026, its #1 holding.
  • Melissa S. Kampmann first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 2,854 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Melissa S. Kampmann's 13F filing for Q2 2026, filed 29 Jul 2026.